• 1. MáJA 2020
    A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder

    A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder

    AUTORI: Olesova, D., Galba, J., Piestansky, J., Celusakova, H., Repiska, G., Babinska, K., Ostatnikova, D., Katina, S., Kovac, A.. ABSTRACT: Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed to
    • 17. APRíLA 2020
    The influence of food intake specificity in children with autism on gut microbiota

    The influence of food intake specificity in children with autism on gut microbiota

    AUTORI: Sashova Tomova, A., Šoltys, K., Keményová, P., Karhánek, M. and Babinská, K. ABSTRACT: Autism spectrum disorder (ASD) is a complex of neurodevelopmental conditions with increasing incidence. The microbiota of children with ASD is distinct from neurotypical children, their food habits are also different, and it is known that nutrient intake influences microbiota in a